Tofacitinib-Induced Acute Pancreatitis in a Patient with Rheumatoid Arthritis: A Case Report and Review of the Literature.

Hiba BoussaaOns HamdiSaoussen MiladiYasmine MakhloufKawther Ben AbdelghaniAlia FazaaAhmed Laatar

Published in: Current drug safety (2024)

Although DIP is still a rare condition, it remains serious with an increased risk of mortality. We intended to alert clinicians that in addition to the known side effects of tofacitinib, pancreatitis may be induced by this drug, especially in predisposed patients.

Keyphrases

rheumatoid arthritis
end stage renal disease
ejection fraction
disease activity
newly diagnosed
peritoneal dialysis
palliative care
ulcerative colitis
drug induced
case report
high glucose
cardiovascular events
emergency department
cardiovascular disease
risk factors
endothelial cells